Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Luliconazole: Completed Phase IIb/III enrollment

Topica completed enrollment of 300 patients in the double-blind, vehicle-controlled, U.S. Phase IIb/III

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE